Global Implantable Cardiac Monitors Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Implantable Cardiac Monitors market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Implantable Cardiac Monitors market."
The implantable Cardiac monitor is a cardiac monitor that can be surgically implanted into the human body. If the patient often has a heartbeat, dizziness, fainting or loss of consciousness, the monitor can detect whether the patient has arrhythmia. Implantable cardiac monitors are typically implanted in the patients left chest wall and their batteries are typically maintained for three years.
The ICM has technologically evolved over the past two decades based on the observed reduction in its size, ease of implant, and remote monitoring and data collection capabilities. As such, the utility of ICMs in the future may be disruptive and lead to broader applications such as QT monitoring following antiarrhythmic drug initiation and anticoagulation management in patients with intermittent atrial fibrillation (AF) who are at risk for stroke.

The global Implantable Cardiac Monitors market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Implantable Cardiac Monitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Implantable Cardiac Monitors market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Abbott Laboratories
    Biotronik 
    Boston Scientific Co
    Edwards Life Science 
    GE Healthcare
    Koninklijke Philips (Philips Healthcare)
    Livanova Plc (Sorin)
    Medtronic Plc
    Nihon Kohden Co
    Phoenix Heart PLLC

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Cardiac Arrhythmias
    Atrial Fibrillation
    Epilepsy & Unexplained Falls

Segment by Application
    Hospitals
    Cardiac Center & Clinics
    Ambulatory Surgical Centers (ASCs)